Gene Symbol | Gene ID | Gene Info |
---|---|---|
MAZ
|
ENSG00000103495.9 | MYC associated zinc finger protein |
ZNF281
|
ENSG00000162702.7 | zinc finger protein 281 |
GTF2F1
|
ENSG00000125651.9 | general transcription factor IIF subunit 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr19_6393244_6393475 | GTF2F1 | 112 | 0.913708 | -0.73 | 2.6e-02 | Click! |
chr19_6393581_6394003 | GTF2F1 | 200 | 0.857832 | -0.70 | 3.4e-02 | Click! |
chr19_6392934_6393166 | GTF2F1 | 166 | 0.880398 | -0.69 | 4.0e-02 | Click! |
chr19_6392626_6392844 | GTF2F1 | 481 | 0.599094 | -0.25 | 5.2e-01 | Click! |
chr16_29818053_29818235 | MAZ | 227 | 0.743145 | -0.56 | 1.2e-01 | Click! |
chr16_29816076_29816359 | MAZ | 1210 | 0.200278 | -0.56 | 1.2e-01 | Click! |
chr16_29817002_29817205 | MAZ | 324 | 0.682622 | -0.47 | 2.0e-01 | Click! |
chr16_29816498_29816694 | MAZ | 831 | 0.309207 | -0.42 | 2.5e-01 | Click! |
chr16_29820021_29820175 | MAZ | 98 | 0.849405 | 0.30 | 4.3e-01 | Click! |
chr1_200306991_200307142 | ZNF281 | 72054 | 0.123598 | -0.80 | 1.0e-02 | Click! |
chr1_200333016_200333167 | ZNF281 | 46029 | 0.191241 | -0.74 | 2.4e-02 | Click! |
chr1_200378123_200378738 | ZNF281 | 690 | 0.812101 | -0.73 | 2.7e-02 | Click! |
chr1_200321506_200321853 | ZNF281 | 57441 | 0.158138 | -0.70 | 3.7e-02 | Click! |
chr1_200452277_200452621 | ZNF281 | 73265 | 0.116304 | 0.68 | 4.3e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chrX_69674453_69675874 | 3.45 |
DLG3 |
discs, large homolog 3 (Drosophila) |
217 |
0.75 |
chrX_54947220_54948504 | 2.67 |
TRO |
trophinin |
41 |
0.97 |
chr19_460012_460518 | 2.37 |
SHC2 |
SHC (Src homology 2 domain containing) transforming protein 2 |
731 |
0.5 |
chr19_6740138_6741070 | 2.13 |
TRIP10 |
thyroid hormone receptor interactor 10 |
325 |
0.81 |
chr19_55684291_55685412 | 2.09 |
SYT5 |
synaptotagmin V |
1083 |
0.28 |
chr16_51185618_51185964 | 2.08 |
SALL1 |
spalt-like transcription factor 1 |
605 |
0.76 |
chr12_7037386_7038830 | 2.04 |
ATN1 |
atrophin 1 |
632 |
0.41 |
chr12_57522507_57523183 | 2.01 |
STAT6 |
signal transducer and activator of transcription 6, interleukin-4 induced |
38 |
0.64 |
chr19_38880573_38880929 | 1.98 |
SPRED3 |
sprouty-related, EVH1 domain containing 3 |
56 |
0.93 |
chr2_160918347_160919586 | 1.95 |
PLA2R1 |
phospholipase A2 receptor 1, 180kDa |
155 |
0.98 |
chr14_23821578_23822379 | 1.91 |
SLC22A17 |
solute carrier family 22, member 17 |
91 |
0.91 |
chr1_75138923_75139762 | 1.87 |
C1orf173 |
chromosome 1 open reading frame 173 |
80 |
0.98 |
chr12_115889903_115890336 | 1.85 |
RP11-116D17.1 |
HCG2038717; Uncharacterized protein |
89302 |
0.1 |
chr19_45754620_45755932 | 1.84 |
MARK4 |
MAP/microtubule affinity-regulating kinase 4 |
726 |
0.57 |
chr1_112532383_112532987 | 1.79 |
KCND3 |
potassium voltage-gated channel, Shal-related subfamily, member 3 |
908 |
0.69 |
chr6_54711000_54712080 | 1.78 |
FAM83B |
family with sequence similarity 83, member B |
29 |
0.98 |
chr15_29966806_29967093 | 1.77 |
RP11-680F8.1 |
|
245 |
0.94 |
chrX_48827968_48828898 | 1.64 |
KCND1 |
potassium voltage-gated channel, Shal-related subfamily, member 1 |
457 |
0.67 |
chr11_62312562_62314176 | 1.59 |
RP11-864I4.4 |
|
102 |
0.64 |
chr2_220307176_220307741 | 1.56 |
SPEG |
SPEG complex locus |
685 |
0.52 |
chr11_118780169_118780810 | 1.56 |
ENSG00000264211 |
. |
928 |
0.3 |
chr2_71127433_71128165 | 1.50 |
VAX2 |
ventral anterior homeobox 2 |
79 |
0.96 |
chr12_130645923_130646373 | 1.48 |
FZD10 |
frizzled family receptor 10 |
856 |
0.76 |
chr2_218843405_218844030 | 1.47 |
TNS1 |
tensin 1 |
60 |
0.79 |
chr10_71389637_71390649 | 1.46 |
C10orf35 |
chromosome 10 open reading frame 35 |
129 |
0.97 |
chr2_70994239_70995345 | 1.46 |
ADD2 |
adducin 2 (beta) |
55 |
0.97 |
chr19_41725215_41725482 | 1.46 |
AXL |
AXL receptor tyrosine kinase |
208 |
0.89 |
chr17_77019963_77021139 | 1.44 |
C1QTNF1 |
C1q and tumor necrosis factor related protein 1 |
208 |
0.91 |
chr22_45898330_45898748 | 1.44 |
FBLN1 |
fibulin 1 |
173 |
0.96 |
chr16_54320248_54320703 | 1.44 |
IRX3 |
iroquois homeobox 3 |
200 |
0.96 |
chr16_73081294_73081963 | 1.43 |
ZFHX3 |
zinc finger homeobox 3 |
646 |
0.76 |
chr14_24837426_24838101 | 1.42 |
NFATC4 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 |
216 |
0.85 |
chr1_29448339_29449190 | 1.41 |
TMEM200B |
transmembrane protein 200B |
249 |
0.93 |
chr10_79396627_79397649 | 1.40 |
KCNMA1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
67 |
0.98 |
chr6_167275533_167276547 | 1.39 |
RPS6KA2 |
ribosomal protein S6 kinase, 90kDa, polypeptide 2 |
1 |
0.98 |
chr12_54367495_54368083 | 1.39 |
HOXC11 |
homeobox C11 |
877 |
0.24 |
chr21_32715523_32716836 | 1.39 |
TIAM1 |
T-cell lymphoma invasion and metastasis 1 |
415 |
0.91 |
chr19_13133635_13134622 | 1.38 |
NFIX |
nuclear factor I/X (CCAAT-binding transcription factor) |
677 |
0.52 |
chr10_112835970_112837137 | 1.31 |
ADRA2A |
adrenoceptor alpha 2A |
237 |
0.95 |
chr7_150779695_150780926 | 1.29 |
TMUB1 |
transmembrane and ubiquitin-like domain containing 1 |
9 |
0.94 |
chr15_40728427_40729026 | 1.26 |
BAHD1 |
bromo adjacent homology domain containing 1 |
3194 |
0.13 |
chr11_66102741_66104078 | 1.26 |
RIN1 |
Ras and Rab interactor 1 |
468 |
0.53 |
chr11_469322_469620 | 1.24 |
RP13-317D12.3 |
|
5572 |
0.1 |
chr9_109622995_109623671 | 1.24 |
ZNF462 |
zinc finger protein 462 |
2045 |
0.37 |
chr12_54391177_54391923 | 1.24 |
HOXC-AS2 |
HOXC cluster antisense RNA 2 |
981 |
0.22 |
chr3_77088107_77088726 | 1.23 |
ROBO2 |
roundabout, axon guidance receptor, homolog 2 (Drosophila) |
621 |
0.83 |
chr19_42754686_42755478 | 1.22 |
ERF |
Ets2 repressor factor |
489 |
0.61 |
chr14_61189738_61190475 | 1.22 |
SIX4 |
SIX homeobox 4 |
746 |
0.69 |
chr4_24472696_24473642 | 1.22 |
ENSG00000265001 |
. |
41714 |
0.15 |
chr4_75718841_75720131 | 1.18 |
BTC |
betacellulin |
410 |
0.91 |
chr20_60941163_60941716 | 1.18 |
LAMA5 |
laminin, alpha 5 |
887 |
0.46 |
chr17_7608077_7608845 | 1.18 |
EFNB3 |
ephrin-B3 |
59 |
0.94 |
chr15_73976688_73977423 | 1.18 |
CD276 |
CD276 molecule |
17 |
0.98 |
chr14_23835061_23835493 | 1.17 |
EFS |
embryonal Fyn-associated substrate |
316 |
0.73 |
chr1_14924992_14926197 | 1.16 |
KAZN |
kazrin, periplakin interacting protein |
381 |
0.93 |
chr22_45403768_45404420 | 1.16 |
PHF21B |
PHD finger protein 21B |
736 |
0.7 |
chr10_135148565_135149526 | 1.16 |
CALY |
calcyon neuron-specific vesicular protein |
1331 |
0.22 |
chr2_112897330_112897707 | 1.15 |
FBLN7 |
fibulin 7 |
1358 |
0.52 |
chr11_125364841_125365435 | 1.15 |
AP000708.1 |
|
28 |
0.88 |
chr3_65583100_65583492 | 1.15 |
MAGI1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
114 |
0.98 |
chr19_14048794_14049313 | 1.15 |
PODNL1 |
podocan-like 1 |
144 |
0.92 |
chr12_127939879_127940274 | 1.15 |
ENSG00000253089 |
. |
134176 |
0.05 |
chr16_2517636_2518674 | 1.15 |
RP11-715J22.2 |
|
59 |
0.92 |
chr5_92918344_92919004 | 1.14 |
NR2F1 |
nuclear receptor subfamily 2, group F, member 1 |
369 |
0.84 |
chr2_200322083_200322803 | 1.14 |
SATB2-AS1 |
SATB2 antisense RNA 1 |
20 |
0.87 |
chr4_187025490_187026623 | 1.14 |
FAM149A |
family with sequence similarity 149, member A |
175 |
0.94 |
chr1_20812928_20813453 | 1.14 |
CAMK2N1 |
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
477 |
0.82 |
chr7_100464814_100466140 | 1.14 |
TRIP6 |
thyroid hormone receptor interactor 6 |
717 |
0.47 |
chr1_117452147_117452928 | 1.13 |
PTGFRN |
prostaglandin F2 receptor inhibitor |
142 |
0.96 |
chr6_88875424_88876640 | 1.13 |
CNR1 |
cannabinoid receptor 1 (brain) |
46 |
0.99 |
chr17_7308835_7309309 | 1.13 |
NLGN2 |
neuroligin 2 |
879 |
0.24 |
chr1_41848138_41848753 | 1.12 |
RP11-399E6.4 |
|
7104 |
0.22 |
chr17_37856067_37857084 | 1.12 |
ERBB2 |
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 |
242 |
0.86 |
chr15_40530958_40531718 | 1.12 |
PAK6 |
p21 protein (Cdc42/Rac)-activated kinase 6 |
46 |
0.96 |
chr14_101034010_101035263 | 1.11 |
BEGAIN |
brain-enriched guanylate kinase-associated |
192 |
0.93 |
chr7_97839825_97840267 | 1.10 |
BHLHA15 |
basic helix-loop-helix family, member a15 |
693 |
0.72 |
chr7_103968956_103969210 | 1.09 |
LHFPL3 |
lipoma HMGIC fusion partner-like 3 |
21 |
0.99 |
chr6_127836765_127837772 | 1.09 |
SOGA3 |
SOGA family member 3 |
491 |
0.85 |
chr2_220436101_220436512 | 1.08 |
OBSL1 |
obscurin-like 1 |
38 |
0.89 |
chr1_231297648_231298418 | 1.07 |
TRIM67 |
tripartite motif containing 67 |
175 |
0.95 |
chr22_46933754_46934840 | 1.07 |
CELSR1 |
cadherin, EGF LAG seven-pass G-type receptor 1 |
1230 |
0.46 |
chr16_4422135_4423224 | 1.07 |
VASN |
vasorin |
830 |
0.49 |
chr7_27153769_27154326 | 1.07 |
HOXA-AS2 |
HOXA cluster antisense RNA 2 |
492 |
0.41 |
chr4_7972052_7972961 | 1.06 |
AFAP1 |
actin filament associated protein 1 |
30853 |
0.14 |
chr11_79151624_79152198 | 1.06 |
TENM4 |
teneurin transmembrane protein 4 |
216 |
0.95 |
chr7_45128395_45129126 | 1.05 |
NACAD |
NAC alpha domain containing |
247 |
0.87 |
chr10_99608959_99609709 | 1.05 |
GOLGA7B |
golgin A7 family, member B |
662 |
0.7 |
chr17_43250076_43250792 | 1.04 |
RP13-890H12.2 |
|
1483 |
0.24 |
chr19_408624_409082 | 1.04 |
C2CD4C |
C2 calcium-dependent domain containing 4C |
286 |
0.86 |
chr15_47476270_47477144 | 1.04 |
SEMA6D |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D |
409 |
0.87 |
chr16_14396121_14396821 | 1.04 |
ENSG00000207639 |
. |
1353 |
0.42 |
chr22_29702254_29703430 | 1.03 |
GAS2L1 |
growth arrest-specific 2 like 1 |
171 |
0.91 |
chr1_39733773_39734441 | 1.03 |
MACF1 |
microtubule-actin crosslinking factor 1 |
92 |
0.97 |
chr4_114900760_114901252 | 1.03 |
ARSJ |
arylsulfatase family, member J |
149 |
0.97 |
chrX_51636554_51637686 | 1.03 |
MAGED1 |
melanoma antigen family D, 1 |
385 |
0.89 |
chr11_119292436_119293234 | 1.03 |
THY1 |
Thy-1 cell surface antigen |
437 |
0.74 |
chr1_244012088_244013269 | 1.02 |
AKT3 |
v-akt murine thymoma viral oncogene homolog 3 |
752 |
0.75 |
chr1_65774988_65775539 | 1.02 |
DNAJC6 |
DnaJ (Hsp40) homolog, subfamily C, member 6 |
35 |
0.98 |
chr2_73511052_73511942 | 1.02 |
FBXO41 |
F-box protein 41 |
59 |
0.96 |
chr17_70117213_70117669 | 1.01 |
SOX9 |
SRY (sex determining region Y)-box 9 |
280 |
0.95 |
chr19_55881999_55882196 | 1.01 |
IL11 |
interleukin 11 |
266 |
0.76 |
chr22_43115644_43116713 | 1.00 |
A4GALT |
alpha 1,4-galactosyltransferase |
24539 |
0.15 |
chr12_53490931_53491757 | 1.00 |
IGFBP6 |
insulin-like growth factor binding protein 6 |
115 |
0.94 |
chr3_77088826_77089151 | 1.00 |
ROBO2 |
roundabout, axon guidance receptor, homolog 2 (Drosophila) |
49 |
0.99 |
chr2_227662938_227664059 | 1.00 |
IRS1 |
insulin receptor substrate 1 |
977 |
0.58 |
chr6_19838575_19839711 | 1.00 |
RP1-167F1.2 |
|
168 |
0.95 |
chr2_79739509_79740065 | 1.00 |
CTNNA2 |
catenin (cadherin-associated protein), alpha 2 |
339 |
0.91 |
chr12_85673938_85674715 | 0.99 |
ALX1 |
ALX homeobox 1 |
441 |
0.91 |
chr18_55469401_55470160 | 0.99 |
ATP8B1 |
ATPase, aminophospholipid transporter, class I, type 8B, member 1 |
547 |
0.82 |
chr19_52191772_52191923 | 0.99 |
ENSG00000207550 |
. |
4018 |
0.11 |
chr19_14315927_14317134 | 0.99 |
LPHN1 |
latrophilin 1 |
451 |
0.77 |
chr9_21974540_21975658 | 0.99 |
CDKN2A |
cyclin-dependent kinase inhibitor 2A |
2 |
0.97 |
chr7_128471351_128471889 | 0.98 |
FLNC |
filamin C, gamma |
1140 |
0.39 |
chr1_201857755_201858533 | 0.98 |
SHISA4 |
shisa family member 4 |
308 |
0.84 |
chr17_76164337_76165654 | 0.97 |
SYNGR2 |
synaptogyrin 2 |
244 |
0.87 |
chr14_105886805_105887920 | 0.97 |
MTA1 |
metastasis associated 1 |
1087 |
0.31 |
chr17_1081882_1082496 | 0.97 |
ABR |
active BCR-related |
889 |
0.58 |
chr21_33244856_33245438 | 0.97 |
HUNK |
hormonally up-regulated Neu-associated kinase |
481 |
0.88 |
chr3_138665230_138665942 | 0.97 |
FOXL2 |
forkhead box L2 |
396 |
0.54 |
chr3_126702505_126703684 | 0.96 |
PLXNA1 |
plexin A1 |
4343 |
0.34 |
chr6_43243068_43244292 | 0.96 |
SLC22A7 |
solute carrier family 22 (organic anion transporter), member 7 |
22056 |
0.11 |
chr7_73082725_73083354 | 0.96 |
VPS37D |
vacuolar protein sorting 37 homolog D (S. cerevisiae) |
816 |
0.48 |
chr7_73868670_73869167 | 0.96 |
GTF2IRD1 |
GTF2I repeat domain containing 1 |
479 |
0.83 |
chr19_55996251_55997143 | 0.96 |
NAT14 |
N-acetyltransferase 14 (GCN5-related, putative) |
96 |
0.92 |
chr18_31802690_31803001 | 0.96 |
RP11-379L18.1 |
|
84 |
0.8 |
chr2_74666737_74667617 | 0.96 |
RTKN |
rhotekin |
533 |
0.54 |
chr6_41605286_41606011 | 0.95 |
MDFI |
MyoD family inhibitor |
528 |
0.74 |
chr3_112929944_112930573 | 0.95 |
BOC |
BOC cell adhesion associated, oncogene regulated |
71 |
0.98 |
chr4_4388085_4389202 | 0.94 |
NSG1 |
Homo sapiens neuron specific gene family member 1 (NSG1), transcript variant 3, mRNA. |
189 |
0.96 |
chr2_133427812_133428020 | 0.94 |
LYPD1 |
LY6/PLAUR domain containing 1 |
138 |
0.97 |
chr11_45376699_45377561 | 0.94 |
SYT13 |
synaptotagmin XIII |
69260 |
0.12 |
chr11_68890438_68890903 | 0.93 |
RP11-554A11.9 |
|
32708 |
0.15 |
chr1_210465594_210466382 | 0.93 |
HHAT |
hedgehog acyltransferase |
35608 |
0.17 |
chr1_113050561_113051464 | 0.93 |
WNT2B |
wingless-type MMTV integration site family, member 2B |
388 |
0.86 |
chr11_63581191_63582006 | 0.93 |
C11orf84 |
chromosome 11 open reading frame 84 |
738 |
0.6 |
chr19_49653084_49654050 | 0.93 |
PPFIA3 |
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 |
2209 |
0.15 |
chr12_85305887_85306488 | 0.93 |
SLC6A15 |
solute carrier family 6 (neutral amino acid transporter), member 15 |
384 |
0.92 |
chr22_37957123_37957770 | 0.93 |
CDC42EP1 |
CDC42 effector protein (Rho GTPase binding) 1 |
959 |
0.43 |
chr22_46366779_46367595 | 0.93 |
WNT7B |
wingless-type MMTV integration site family, member 7B |
1408 |
0.38 |
chr1_201436884_201437966 | 0.93 |
PHLDA3 |
pleckstrin homology-like domain, family A, member 3 |
887 |
0.55 |
chr17_11143475_11144119 | 0.92 |
SHISA6 |
shisa family member 6 |
783 |
0.71 |
chr15_93615075_93616283 | 0.92 |
RGMA |
repulsive guidance molecule family member a |
695 |
0.78 |
chr19_49567989_49568490 | 0.92 |
NTF4 |
neurotrophin 4 |
72 |
0.9 |
chr2_159825200_159826543 | 0.92 |
TANC1 |
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 |
688 |
0.73 |
chr14_104582609_104583337 | 0.92 |
ENSG00000207568 |
. |
769 |
0.59 |
chr6_80656707_80657785 | 0.91 |
ELOVL4 |
ELOVL fatty acid elongase 4 |
51 |
0.98 |
chr19_48222672_48222903 | 0.91 |
EHD2 |
EH-domain containing 2 |
6108 |
0.15 |
chr11_1592308_1592898 | 0.91 |
KRTAP5-AS1 |
KRTAP5-1/KRTAP5-2 antisense RNA 1 |
20 |
0.9 |
chr7_22589223_22589977 | 0.91 |
AC002480.3 |
|
13356 |
0.2 |
chr2_183901778_183902686 | 0.91 |
NCKAP1 |
NCK-associated protein 1 |
968 |
0.52 |
chr6_13924445_13925088 | 0.90 |
RNF182 |
ring finger protein 182 |
89 |
0.98 |
chr5_1110808_1112337 | 0.90 |
SLC12A7 |
solute carrier family 12 (potassium/chloride transporter), member 7 |
578 |
0.75 |
chr7_33945201_33945548 | 0.90 |
BMPER |
BMP binding endothelial regulator |
229 |
0.96 |
chr5_175224623_175224774 | 0.90 |
CPLX2 |
complexin 2 |
953 |
0.65 |
chr2_69240059_69240934 | 0.90 |
ANTXR1 |
anthrax toxin receptor 1 |
33 |
0.98 |
chr2_110872434_110873339 | 0.90 |
MALL |
mal, T-cell differentiation protein-like |
713 |
0.63 |
chr14_99712277_99712758 | 0.90 |
AL109767.1 |
|
16768 |
0.21 |
chr16_31483566_31484168 | 0.90 |
TGFB1I1 |
transforming growth factor beta 1 induced transcript 1 |
338 |
0.75 |
chr3_192126971_192127690 | 0.89 |
FGF12 |
fibroblast growth factor 12 |
492 |
0.87 |
chr1_956379_957022 | 0.89 |
AGRN |
agrin |
1197 |
0.27 |
chr1_1291581_1291732 | 0.89 |
MXRA8 |
matrix-remodelling associated 8 |
2259 |
0.11 |
chr7_55087572_55088165 | 0.89 |
EGFR |
epidermal growth factor receptor |
1057 |
0.68 |
chr14_101543718_101544133 | 0.88 |
ENSG00000207959 |
. |
10864 |
0.02 |
chr9_116916175_116916824 | 0.88 |
COL27A1 |
collagen, type XXVII, alpha 1 |
1341 |
0.49 |
chr5_176074525_176075535 | 0.88 |
TSPAN17 |
tetraspanin 17 |
409 |
0.77 |
chr10_23384088_23384239 | 0.88 |
MSRB2 |
methionine sulfoxide reductase B2 |
272 |
0.92 |
chr17_70587270_70588900 | 0.88 |
ENSG00000200783 |
. |
72206 |
0.12 |
chr12_115130463_115130662 | 0.88 |
TBX3 |
T-box 3 |
8593 |
0.23 |
chr8_97172057_97172969 | 0.87 |
GDF6 |
growth differentiation factor 6 |
507 |
0.84 |
chrX_107018688_107019917 | 0.87 |
TSC22D3 |
TSC22 domain family, member 3 |
43 |
0.97 |
chr6_41515017_41516078 | 0.87 |
RP11-328M4.2 |
|
261 |
0.86 |
chr19_13906290_13907522 | 0.87 |
ZSWIM4 |
zinc finger, SWIM-type containing 4 |
632 |
0.39 |
chr1_76081136_76081714 | 0.87 |
SLC44A5 |
solute carrier family 44, member 5 |
4624 |
0.27 |
chrX_83442690_83443328 | 0.87 |
RPS6KA6 |
ribosomal protein S6 kinase, 90kDa, polypeptide 6 |
76 |
0.98 |
chr9_130159461_130160475 | 0.86 |
SLC2A8 |
solute carrier family 2 (facilitated glucose transporter), member 8 |
305 |
0.87 |
chr19_44139197_44139620 | 0.86 |
CADM4 |
cell adhesion molecule 4 |
4583 |
0.1 |
chr20_49307514_49308405 | 0.86 |
FAM65C |
family with sequence similarity 65, member C |
43 |
0.97 |
chr17_6459033_6459314 | 0.86 |
PITPNM3 |
PITPNM family member 3 |
607 |
0.7 |
chr2_127976513_127977351 | 0.86 |
CYP27C1 |
cytochrome P450, family 27, subfamily C, polypeptide 1 |
722 |
0.74 |
chr2_74606600_74607395 | 0.86 |
DCTN1 |
dynactin 1 |
413 |
0.73 |
chr16_67687126_67687441 | 0.86 |
ACD |
adrenocortical dysplasia homolog (mouse) |
5883 |
0.1 |
chr14_103673729_103674048 | 0.86 |
ENSG00000239117 |
. |
4365 |
0.24 |
chr1_33207592_33208218 | 0.86 |
KIAA1522 |
KIAA1522 |
419 |
0.8 |
chr14_105436556_105437076 | 0.86 |
AHNAK2 |
AHNAK nucleoprotein 2 |
7878 |
0.16 |
chr11_57406082_57406969 | 0.86 |
AP000662.4 |
|
676 |
0.5 |
chr6_34205466_34206794 | 0.86 |
HMGA1 |
high mobility group AT-hook 1 |
438 |
0.85 |
chr2_119592973_119593692 | 0.85 |
EN1 |
engrailed homeobox 1 |
11922 |
0.28 |
chr3_184037306_184037783 | 0.85 |
EIF4G1 |
eukaryotic translation initiation factor 4 gamma, 1 |
1 |
0.95 |
chr1_31380173_31380807 | 0.85 |
SDC3 |
syndecan 3 |
1118 |
0.44 |
chr17_6923216_6923383 | 0.85 |
MIR497HG |
mir-497-195 cluster host gene (non-protein coding) |
321 |
0.56 |
chr1_180881914_180882730 | 0.85 |
KIAA1614 |
KIAA1614 |
3 |
0.98 |
chr11_116064544_116064938 | 0.85 |
ENSG00000238625 |
. |
126320 |
0.06 |
chr3_128207705_128209147 | 0.85 |
RP11-475N22.4 |
|
326 |
0.79 |
chr7_1329739_1330674 | 0.85 |
UNCX |
UNC homeobox |
57663 |
0.12 |
chr9_89952337_89952906 | 0.85 |
ENSG00000212421 |
. |
77256 |
0.11 |
chr1_68298302_68298834 | 0.84 |
GNG12-AS1 |
GNG12 antisense RNA 1 |
576 |
0.46 |
chr17_17696076_17696345 | 0.84 |
RAI1 |
retinoic acid induced 1 |
53 |
0.96 |
chr17_27949136_27950218 | 0.84 |
CORO6 |
coronin 6 |
237 |
0.62 |
chr16_69140450_69141374 | 0.84 |
HAS3 |
hyaluronan synthase 3 |
400 |
0.81 |
chr22_17680298_17680570 | 0.84 |
CECR1 |
cat eye syndrome chromosome region, candidate 1 |
239 |
0.92 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 4.9 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
1.4 | 4.3 | GO:0060677 | ureteric bud elongation(GO:0060677) |
1.3 | 2.5 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
1.1 | 3.3 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
1.0 | 5.1 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.9 | 1.8 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.9 | 2.6 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.8 | 3.3 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.7 | 2.2 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.7 | 2.1 | GO:0033088 | negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.7 | 2.8 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.7 | 2.7 | GO:1900078 | positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.7 | 2.0 | GO:0051451 | myoblast migration(GO:0051451) |
0.6 | 1.9 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.6 | 2.6 | GO:0070141 | response to UV-A(GO:0070141) |
0.6 | 2.5 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.6 | 1.8 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.6 | 1.8 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
0.6 | 1.1 | GO:0072070 | loop of Henle development(GO:0072070) |
0.6 | 4.0 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.6 | 1.1 | GO:0003181 | atrioventricular valve development(GO:0003171) atrioventricular valve morphogenesis(GO:0003181) |
0.5 | 1.6 | GO:0021508 | floor plate formation(GO:0021508) |
0.5 | 1.6 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.5 | 0.5 | GO:0033084 | regulation of immature T cell proliferation in thymus(GO:0033084) |
0.5 | 1.6 | GO:0032351 | negative regulation of hormone metabolic process(GO:0032351) negative regulation of hormone biosynthetic process(GO:0032353) |
0.5 | 1.6 | GO:0008049 | male courtship behavior(GO:0008049) |
0.5 | 1.6 | GO:0048289 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
0.5 | 0.5 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.5 | 0.5 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.5 | 1.0 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.5 | 0.5 | GO:0060594 | mammary gland specification(GO:0060594) |
0.5 | 1.4 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.5 | 1.4 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) pattern specification involved in metanephros development(GO:0072268) |
0.5 | 1.9 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.5 | 0.9 | GO:0007619 | courtship behavior(GO:0007619) |
0.5 | 1.8 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.4 | 0.4 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.4 | 1.3 | GO:0071883 | adrenergic receptor signaling pathway(GO:0071875) activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.4 | 0.9 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.4 | 2.1 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.4 | 1.3 | GO:0048865 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
0.4 | 2.1 | GO:0001946 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.4 | 1.2 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.4 | 1.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.4 | 1.6 | GO:1903392 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
0.4 | 0.4 | GO:0061213 | positive regulation of mesonephros development(GO:0061213) positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.4 | 1.2 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
0.4 | 5.0 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.4 | 0.8 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.4 | 1.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.4 | 0.7 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.4 | 1.5 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.4 | 1.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.4 | 0.4 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.3 | 1.7 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.3 | 0.3 | GO:0060513 | prostatic bud formation(GO:0060513) |
0.3 | 2.3 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.3 | 0.6 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.3 | 1.3 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) |
0.3 | 1.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.3 | 1.3 | GO:0097094 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.3 | 1.3 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.3 | 2.2 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.3 | 0.9 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.3 | 0.9 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.3 | 2.1 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.3 | 2.7 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.3 | 0.3 | GO:0042637 | catagen(GO:0042637) |
0.3 | 1.4 | GO:0010665 | striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.3 | 0.9 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.3 | 1.1 | GO:0048242 | epinephrine transport(GO:0048241) epinephrine secretion(GO:0048242) |
0.3 | 0.8 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.3 | 0.8 | GO:0035583 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.3 | 0.8 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.3 | 1.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.3 | 1.6 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.3 | 0.8 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.3 | 0.8 | GO:0034653 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.3 | 0.5 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.3 | 1.0 | GO:0008218 | bioluminescence(GO:0008218) |
0.3 | 1.6 | GO:1902668 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
0.3 | 0.5 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.3 | 1.8 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.3 | 1.5 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.3 | 1.0 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.3 | 1.0 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
0.3 | 0.8 | GO:0022601 | menstrual cycle phase(GO:0022601) |
0.2 | 0.2 | GO:0060581 | ventral spinal cord interneuron differentiation(GO:0021514) ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.2 | 3.2 | GO:0035329 | hippo signaling(GO:0035329) |
0.2 | 0.2 | GO:0032344 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
0.2 | 2.2 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.2 | 0.7 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.2 | 0.9 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.2 | 4.9 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.2 | 0.2 | GO:0021683 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.2 | 1.6 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.2 | 1.6 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.2 | 0.7 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.2 | 0.2 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.2 | 0.9 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.2 | 0.7 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.2 | 0.7 | GO:0014824 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.2 | 0.2 | GO:0001705 | ectoderm formation(GO:0001705) |
0.2 | 0.9 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
0.2 | 0.4 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.2 | 0.7 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.2 | 0.9 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.2 | 1.3 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.2 | 0.2 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) positive regulation of protein kinase C signaling(GO:0090037) |
0.2 | 0.4 | GO:0051446 | positive regulation of meiotic nuclear division(GO:0045836) positive regulation of meiotic cell cycle(GO:0051446) |
0.2 | 0.4 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.2 | 1.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.2 | 1.9 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.2 | 0.6 | GO:0001757 | somite specification(GO:0001757) |
0.2 | 1.7 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.2 | 1.4 | GO:0045661 | regulation of myoblast differentiation(GO:0045661) |
0.2 | 0.2 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
0.2 | 0.8 | GO:0001738 | morphogenesis of a polarized epithelium(GO:0001738) |
0.2 | 0.8 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.2 | 2.0 | GO:0035567 | non-canonical Wnt signaling pathway(GO:0035567) |
0.2 | 3.3 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.2 | 0.6 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 1.9 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.2 | 0.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.2 | 2.1 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.2 | 0.6 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.2 | 0.6 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.2 | 1.7 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.2 | 0.6 | GO:0043129 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.2 | 0.4 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.2 | 0.7 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.2 | 0.2 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.2 | 0.2 | GO:0035112 | genitalia morphogenesis(GO:0035112) |
0.2 | 0.2 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.2 | 0.2 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.2 | 0.4 | GO:0032823 | regulation of natural killer cell differentiation(GO:0032823) positive regulation of natural killer cell differentiation(GO:0032825) |
0.2 | 3.9 | GO:0007566 | embryo implantation(GO:0007566) |
0.2 | 0.5 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 0.5 | GO:0008615 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.2 | 0.7 | GO:0060013 | righting reflex(GO:0060013) |
0.2 | 0.3 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.2 | 0.9 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.2 | 0.2 | GO:0090109 | regulation of focal adhesion assembly(GO:0051893) regulation of cell-substrate junction assembly(GO:0090109) regulation of cell junction assembly(GO:1901888) regulation of adherens junction organization(GO:1903391) |
0.2 | 0.2 | GO:0003161 | cardiac conduction system development(GO:0003161) |
0.2 | 0.3 | GO:0044266 | multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) multicellular organismal protein metabolic process(GO:0044268) |
0.2 | 1.0 | GO:0031269 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 0.2 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.2 | 1.3 | GO:0032373 | positive regulation of sterol transport(GO:0032373) positive regulation of cholesterol transport(GO:0032376) |
0.2 | 0.5 | GO:0090102 | cochlea development(GO:0090102) |
0.2 | 0.2 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.2 | 0.2 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.2 | 0.7 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.2 | 0.2 | GO:0048841 | regulation of axon extension involved in axon guidance(GO:0048841) regulation of axon guidance(GO:1902667) |
0.2 | 0.7 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.2 | 0.3 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.2 | 0.3 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.2 | 0.5 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.2 | 0.6 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.2 | 0.5 | GO:0060039 | pericardium development(GO:0060039) |
0.2 | 2.2 | GO:0051492 | regulation of stress fiber assembly(GO:0051492) |
0.2 | 0.5 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.2 | 1.4 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.2 | 0.2 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.2 | 0.3 | GO:0009405 | pathogenesis(GO:0009405) |
0.2 | 0.2 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.2 | 0.2 | GO:0033079 | immature T cell proliferation(GO:0033079) |
0.2 | 1.5 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.2 | 0.8 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.2 | 0.3 | GO:0001945 | lymph vessel development(GO:0001945) |
0.1 | 0.4 | GO:1904377 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.1 | 0.4 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.1 | 1.0 | GO:0003156 | regulation of organ formation(GO:0003156) |
0.1 | 0.9 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.1 | 0.4 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.1 | 0.1 | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) |
0.1 | 1.2 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.1 | 0.3 | GO:0032261 | purine nucleotide salvage(GO:0032261) |
0.1 | 0.3 | GO:1903053 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.4 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 1.1 | GO:0030325 | adrenal gland development(GO:0030325) |
0.1 | 0.6 | GO:0060438 | trachea development(GO:0060438) |
0.1 | 0.3 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.4 | GO:0032610 | interleukin-1 alpha production(GO:0032610) interleukin-1 alpha secretion(GO:0050703) |
0.1 | 0.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.1 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) positive regulation of cholesterol homeostasis(GO:2000189) |
0.1 | 0.1 | GO:0021591 | ventricular system development(GO:0021591) |
0.1 | 0.4 | GO:0021983 | pituitary gland development(GO:0021983) |
0.1 | 0.1 | GO:0061299 | retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 0.4 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 | 0.7 | GO:0048333 | mesodermal cell differentiation(GO:0048333) |
0.1 | 1.1 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.1 | 1.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.7 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.1 | 0.7 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 2.4 | GO:0042490 | mechanoreceptor differentiation(GO:0042490) |
0.1 | 0.1 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.1 | 0.5 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.1 | 1.9 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.3 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.1 | 0.3 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.1 | 0.3 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
0.1 | 1.2 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.1 | 0.5 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 0.8 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 0.4 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.6 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.1 | 0.3 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.1 | 0.4 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.1 | 0.3 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.1 | 1.8 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.1 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.1 | 0.1 | GO:0060596 | mammary placode formation(GO:0060596) |
0.1 | 0.2 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.1 | 0.2 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.7 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 1.1 | GO:0098876 | Golgi to plasma membrane transport(GO:0006893) vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.1 | 0.7 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.1 | 1.3 | GO:0008038 | neuron recognition(GO:0008038) |
0.1 | 0.4 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.1 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.1 | 0.4 | GO:0043113 | receptor clustering(GO:0043113) |
0.1 | 0.4 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.1 | 0.6 | GO:0007616 | long-term memory(GO:0007616) |
0.1 | 0.7 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.1 | GO:0021554 | optic nerve development(GO:0021554) |
0.1 | 0.7 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.3 | GO:0071800 | podosome assembly(GO:0071800) |
0.1 | 0.7 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.1 | 0.6 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.1 | 0.5 | GO:0032288 | myelin assembly(GO:0032288) |
0.1 | 0.6 | GO:0008347 | glial cell migration(GO:0008347) |
0.1 | 0.7 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 1.7 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.1 | 0.3 | GO:0034201 | response to oleic acid(GO:0034201) |
0.1 | 0.2 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 1.1 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.1 | 0.1 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
0.1 | 1.7 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.1 | 0.1 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) |
0.1 | 0.3 | GO:0003151 | outflow tract morphogenesis(GO:0003151) |
0.1 | 0.2 | GO:0048265 | response to pain(GO:0048265) |
0.1 | 0.1 | GO:0099504 | synaptic vesicle cycle(GO:0099504) |
0.1 | 1.0 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.1 | 1.0 | GO:0009650 | UV protection(GO:0009650) |
0.1 | 0.8 | GO:0047496 | vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
0.1 | 0.8 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.4 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.1 | 0.4 | GO:0050807 | regulation of synapse organization(GO:0050807) |
0.1 | 0.3 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 3.9 | GO:0001764 | neuron migration(GO:0001764) |
0.1 | 1.1 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.1 | 0.2 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.1 | 0.1 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.1 | 2.4 | GO:0046068 | cGMP metabolic process(GO:0046068) |
0.1 | 0.4 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.1 | 0.2 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.1 | 0.9 | GO:0007530 | sex determination(GO:0007530) |
0.1 | 0.1 | GO:0048486 | parasympathetic nervous system development(GO:0048486) |
0.1 | 0.5 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.1 | 1.3 | GO:0017158 | regulation of calcium ion-dependent exocytosis(GO:0017158) |
0.1 | 0.9 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.5 | GO:0046337 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.1 | 0.3 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 12.2 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 2.7 | GO:0046847 | filopodium assembly(GO:0046847) |
0.1 | 2.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 0.2 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.1 | 1.0 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.4 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.1 | 0.4 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.4 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.3 | GO:0048617 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.1 | 0.3 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.1 | 0.4 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 1.2 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.1 | 0.3 | GO:0009648 | photoperiodism(GO:0009648) |
0.1 | 0.2 | GO:0001554 | luteolysis(GO:0001554) |
0.1 | 0.3 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.1 | 0.4 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.7 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.5 | GO:0009651 | response to salt stress(GO:0009651) |
0.1 | 0.1 | GO:0061028 | establishment of endothelial barrier(GO:0061028) |
0.1 | 0.1 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.1 | 0.3 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 0.3 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 0.1 | GO:0022011 | Schwann cell development(GO:0014044) myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.1 | 0.5 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.1 | 0.3 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 1.1 | GO:0030815 | negative regulation of cAMP metabolic process(GO:0030815) negative regulation of cAMP biosynthetic process(GO:0030818) |
0.1 | 0.3 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.1 | 0.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.2 | GO:0007132 | meiotic metaphase I(GO:0007132) |
0.1 | 0.8 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) myoblast fusion(GO:0007520) |
0.1 | 0.2 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
0.1 | 2.2 | GO:0048839 | inner ear development(GO:0048839) |
0.1 | 0.2 | GO:0070295 | renal water absorption(GO:0070295) |
0.1 | 0.5 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.2 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 0.2 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.6 | GO:0030318 | melanocyte differentiation(GO:0030318) pigment cell differentiation(GO:0050931) |
0.1 | 1.9 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.1 | 0.2 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 0.2 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.1 | 0.6 | GO:0009437 | amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
0.1 | 0.8 | GO:0007613 | memory(GO:0007613) |
0.1 | 21.0 | GO:0007409 | axonogenesis(GO:0007409) |
0.1 | 0.3 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 1.1 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.1 | 0.1 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.1 | 0.2 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.1 | 0.2 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.1 | 1.0 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 0.2 | GO:0090505 | wound healing, spreading of epidermal cells(GO:0035313) wound healing, spreading of cells(GO:0044319) epiboly(GO:0090504) epiboly involved in wound healing(GO:0090505) |
0.1 | 0.8 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.1 | 9.1 | GO:0006813 | potassium ion transport(GO:0006813) |
0.1 | 0.3 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 0.1 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
0.1 | 0.1 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0014808) calcium ion transport from endoplasmic reticulum to cytosol(GO:1903514) |
0.1 | 0.2 | GO:0061384 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.1 | 0.5 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.2 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.1 | 0.1 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.5 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.1 | 0.6 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.1 | 0.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.5 | GO:0002021 | response to dietary excess(GO:0002021) |
0.1 | 0.1 | GO:0060044 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of cardiac muscle tissue development(GO:0055026) negative regulation of cardiac muscle cell proliferation(GO:0060044) negative regulation of heart growth(GO:0061117) |
0.1 | 0.3 | GO:0006531 | aspartate metabolic process(GO:0006531) aspartate catabolic process(GO:0006533) |
0.1 | 4.4 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.1 | GO:0048483 | autonomic nervous system development(GO:0048483) |
0.1 | 0.2 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.1 | 0.1 | GO:1900121 | regulation of receptor binding(GO:1900120) negative regulation of receptor binding(GO:1900121) |
0.1 | 0.1 | GO:0097501 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
0.1 | 0.2 | GO:0043586 | tongue development(GO:0043586) |
0.1 | 0.7 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 0.1 | GO:0015793 | glycerol transport(GO:0015793) |
0.1 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.3 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.1 | 0.3 | GO:0071445 | obsolete cellular response to protein stimulus(GO:0071445) |
0.1 | 0.7 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.1 | 0.1 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.1 | 1.5 | GO:0007588 | excretion(GO:0007588) |
0.1 | 0.1 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.1 | 0.3 | GO:0008593 | regulation of Notch signaling pathway(GO:0008593) |
0.1 | 0.3 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 0.4 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.4 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.1 | 0.2 | GO:0031529 | ruffle organization(GO:0031529) |
0.1 | 0.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.2 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.1 | 0.1 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.1 | 0.3 | GO:0045176 | apical protein localization(GO:0045176) |
0.1 | 0.1 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 0.2 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.2 | GO:0032069 | regulation of nuclease activity(GO:0032069) |
0.1 | 0.2 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.1 | 0.1 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.1 | 0.8 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.1 | GO:0048245 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.1 | 0.1 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.4 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
0.1 | 0.1 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.1 | 0.1 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.1 | 0.2 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 0.2 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 0.2 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.1 | GO:0021854 | hypothalamus development(GO:0021854) |
0.1 | 0.2 | GO:0007512 | adult heart development(GO:0007512) |
0.1 | 0.2 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.1 | 0.2 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.1 | 0.1 | GO:1903726 | negative regulation of phospholipid metabolic process(GO:1903726) |
0.1 | 0.2 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.1 | 0.2 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.1 | 0.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.1 | GO:0033197 | response to vitamin E(GO:0033197) |
0.1 | 0.1 | GO:0030901 | midbrain development(GO:0030901) |
0.1 | 0.1 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.1 | 0.1 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.1 | 0.1 | GO:0009414 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.1 | 0.6 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
0.1 | 0.4 | GO:0048332 | mesoderm formation(GO:0001707) mesoderm morphogenesis(GO:0048332) |
0.1 | 0.1 | GO:0009111 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.1 | 0.1 | GO:0070091 | glucagon secretion(GO:0070091) |
0.1 | 0.2 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.1 | GO:0032109 | positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.1 | 0.2 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.1 | 0.1 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.1 | 0.4 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.1 | GO:1902742 | apoptotic process involved in development(GO:1902742) |
0.1 | 0.1 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.1 | 0.1 | GO:0032095 | regulation of response to food(GO:0032095) |
0.1 | 0.2 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 0.8 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.2 | GO:0021536 | diencephalon development(GO:0021536) |
0.0 | 0.2 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.0 | 0.1 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.0 | 0.1 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.0 | 0.4 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.0 | 0.0 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.3 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 0.2 | GO:0051153 | regulation of striated muscle cell differentiation(GO:0051153) |
0.0 | 0.4 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.0 | 0.2 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.0 | 0.1 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.0 | 0.7 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.1 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.0 | 0.2 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 0.3 | GO:0031114 | negative regulation of microtubule depolymerization(GO:0007026) negative regulation of microtubule polymerization or depolymerization(GO:0031111) regulation of microtubule depolymerization(GO:0031114) |
0.0 | 0.1 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.0 | 0.0 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.0 | 0.2 | GO:0007431 | salivary gland development(GO:0007431) |
0.0 | 0.0 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.0 | 0.0 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.0 | 0.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.0 | GO:0033024 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
0.0 | 0.1 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.0 | 0.1 | GO:0000422 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.0 | 0.4 | GO:0009712 | catecholamine metabolic process(GO:0006584) catechol-containing compound metabolic process(GO:0009712) |
0.0 | 0.3 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.0 | 1.7 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.1 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.0 | GO:1903727 | positive regulation of phospholipid metabolic process(GO:1903727) |
0.0 | 0.1 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.0 | 0.0 | GO:0072176 | nephric duct development(GO:0072176) |
0.0 | 0.4 | GO:0019359 | nicotinamide nucleotide biosynthetic process(GO:0019359) |
0.0 | 0.2 | GO:1901862 | negative regulation of striated muscle tissue development(GO:0045843) negative regulation of muscle tissue development(GO:1901862) |
0.0 | 0.6 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.1 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.0 | 0.2 | GO:0043649 | glutamate catabolic process(GO:0006538) dicarboxylic acid catabolic process(GO:0043649) |
0.0 | 0.5 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.0 | 0.1 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.0 | 0.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.0 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.0 | 0.0 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.0 | 0.0 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.0 | 0.0 | GO:0060068 | vagina development(GO:0060068) |
0.0 | 0.3 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.0 | 0.3 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.8 | GO:0046661 | male sex differentiation(GO:0046661) |
0.0 | 0.2 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.0 | 0.5 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.1 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.1 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.0 | 0.1 | GO:0070828 | heterochromatin assembly(GO:0031507) heterochromatin organization(GO:0070828) |
0.0 | 0.2 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.0 | 3.7 | GO:0001501 | skeletal system development(GO:0001501) |
0.0 | 0.3 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.0 | GO:0060456 | positive regulation of digestive system process(GO:0060456) |
0.0 | 0.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) negative regulation of lipase activity(GO:0060192) |
0.0 | 0.2 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.0 | 0.1 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.0 | 0.1 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.0 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.1 | GO:0001508 | action potential(GO:0001508) |
0.0 | 0.1 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.1 | GO:0032094 | response to food(GO:0032094) |
0.0 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.2 | GO:1904407 | positive regulation of nitric oxide biosynthetic process(GO:0045429) positive regulation of reactive oxygen species biosynthetic process(GO:1903428) positive regulation of nitric oxide metabolic process(GO:1904407) |
0.0 | 0.1 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.0 | 1.1 | GO:0009408 | response to heat(GO:0009408) |
0.0 | 0.1 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.0 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.0 | 0.2 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.1 | GO:0043247 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.0 | 0.4 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.0 | 0.2 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.4 | GO:0042633 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
0.0 | 0.1 | GO:0031345 | negative regulation of cell projection organization(GO:0031345) |
0.0 | 0.3 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.0 | 0.0 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.0 | 0.1 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.0 | 2.2 | GO:0007517 | muscle organ development(GO:0007517) |
0.0 | 0.1 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.0 | 0.1 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.1 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.2 | GO:0032456 | endocytic recycling(GO:0032456) |
0.0 | 0.0 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.0 | 0.1 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.0 | 0.0 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.0 | 0.2 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.1 | GO:0033144 | negative regulation of intracellular steroid hormone receptor signaling pathway(GO:0033144) |
0.0 | 0.1 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.0 | 0.0 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.0 | 0.1 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.0 | 0.3 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.0 | 0.1 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
0.0 | 0.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.1 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.0 | 0.1 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.0 | 0.0 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.1 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.0 | 0.1 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.0 | 0.0 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.0 | 0.0 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.1 | GO:0048066 | developmental pigmentation(GO:0048066) |
0.0 | 0.3 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
0.0 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.0 | 0.1 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.0 | 0.0 | GO:0035883 | enteroendocrine cell differentiation(GO:0035883) |
0.0 | 0.0 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.0 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.5 | GO:0044344 | cellular response to fibroblast growth factor stimulus(GO:0044344) response to fibroblast growth factor(GO:0071774) |
0.0 | 0.0 | GO:0017085 | response to insecticide(GO:0017085) |
0.0 | 0.0 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.0 | GO:0050805 | negative regulation of synaptic transmission(GO:0050805) |
0.0 | 0.1 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) protein side chain deglutamylation(GO:0035610) |
0.0 | 1.0 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.0 | 0.0 | GO:0034651 | cortisol metabolic process(GO:0034650) cortisol biosynthetic process(GO:0034651) |
0.0 | 0.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.1 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.0 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.0 | 0.0 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.0 | 0.1 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.0 | 0.1 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.0 | 0.1 | GO:0031427 | response to methotrexate(GO:0031427) |
0.0 | 0.0 | GO:0046666 | retinal cell programmed cell death(GO:0046666) |
0.0 | 0.0 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.0 | 0.1 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade(GO:0070374) |
0.0 | 0.0 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.0 | 0.1 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.0 | 0.0 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.0 | 0.0 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.0 | 0.0 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.0 | 0.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.2 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.0 | 0.0 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.0 | 0.0 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.1 | GO:0035272 | exocrine system development(GO:0035272) |
0.0 | 0.1 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.0 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.1 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.0 | 0.0 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.0 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of reactive oxygen species biosynthetic process(GO:1903427) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.0 | 0.1 | GO:0015824 | proline transport(GO:0015824) |
0.0 | 0.1 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.0 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.0 | 0.0 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.0 | 0.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.0 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.0 | 0.2 | GO:0030216 | keratinocyte differentiation(GO:0030216) |
0.0 | 0.0 | GO:0010820 | T cell chemotaxis(GO:0010818) regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) T cell migration(GO:0072678) regulation of lymphocyte chemotaxis(GO:1901623) regulation of lymphocyte migration(GO:2000401) positive regulation of lymphocyte migration(GO:2000403) regulation of T cell migration(GO:2000404) positive regulation of T cell migration(GO:2000406) |
0.0 | 0.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.1 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.0 | 0.0 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.0 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.2 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.0 | GO:0032506 | cytokinetic process(GO:0032506) |
0.0 | 0.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.1 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.0 | 0.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.1 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 0.0 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.1 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.0 | 0.0 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.0 | 0.0 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
0.0 | 0.0 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.0 | 0.0 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.0 | 0.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.8 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.6 | 3.3 | GO:0010369 | chromocenter(GO:0010369) |
0.5 | 1.5 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.5 | 1.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.4 | 1.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.4 | 2.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.4 | 1.2 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.4 | 1.4 | GO:0005638 | lamin filament(GO:0005638) |
0.4 | 2.1 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.4 | 1.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.4 | 0.4 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.3 | 0.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.3 | 0.3 | GO:0033268 | node of Ranvier(GO:0033268) |
0.3 | 2.1 | GO:0030673 | axolemma(GO:0030673) |
0.3 | 0.9 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.3 | 1.2 | GO:0032059 | bleb(GO:0032059) |
0.3 | 2.0 | GO:0031527 | filopodium membrane(GO:0031527) |
0.3 | 0.3 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.3 | 1.6 | GO:0001527 | microfibril(GO:0001527) |
0.3 | 1.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.3 | 5.3 | GO:0005581 | collagen trimer(GO:0005581) |
0.3 | 1.6 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.2 | 1.4 | GO:0031430 | M band(GO:0031430) |
0.2 | 1.2 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 4.4 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 0.9 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.2 | 1.1 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.2 | 0.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 1.0 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 0.8 | GO:0042583 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.2 | 1.4 | GO:0030122 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.2 | 0.4 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.2 | 0.6 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.2 | 0.6 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 0.5 | GO:0032449 | CBM complex(GO:0032449) |
0.2 | 14.4 | GO:0060076 | excitatory synapse(GO:0060076) |
0.2 | 2.1 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.2 | 43.0 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.2 | 0.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 0.5 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.2 | 2.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 1.2 | GO:0043034 | costamere(GO:0043034) |
0.1 | 0.9 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.1 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.1 | 0.3 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.1 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 6.4 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 9.9 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 0.6 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 0.9 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 1.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 2.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 1.9 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.5 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.2 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.6 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.2 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 11.4 | GO:0070161 | anchoring junction(GO:0070161) |
0.1 | 8.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 4.5 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 0.4 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 1.0 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.3 | GO:0030288 | outer membrane-bounded periplasmic space(GO:0030288) periplasmic space(GO:0042597) |
0.1 | 0.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 0.7 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 2.6 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 9.2 | GO:0005911 | cell-cell junction(GO:0005911) |
0.1 | 0.1 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.1 | 0.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.7 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.4 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.1 | 0.2 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.1 | 0.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 1.0 | GO:0044447 | axoneme part(GO:0044447) |
0.1 | 0.3 | GO:0000801 | central element(GO:0000801) |
0.1 | 0.1 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 0.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.7 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 0.3 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.1 | 0.7 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.4 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 3.1 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 1.2 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 0.8 | GO:0016460 | myosin II complex(GO:0016460) |
0.1 | 0.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 0.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.1 | 5.3 | GO:0043025 | neuronal cell body(GO:0043025) |
0.1 | 0.3 | GO:0043679 | axon terminus(GO:0043679) |
0.1 | 0.3 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 0.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 0.2 | GO:0044421 | extracellular region part(GO:0044421) |
0.0 | 1.0 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 1.2 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.3 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.8 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.0 | 0.1 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.0 | 1.2 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.0 | 25.1 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.5 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.2 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 0.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 1.8 | GO:0030425 | dendrite(GO:0030425) |
0.0 | 0.1 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 0.5 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 0.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 30.4 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.0 | 0.7 | GO:0030118 | clathrin coat(GO:0030118) |
0.0 | 0.0 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.2 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.0 | 0.3 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.0 | 1.3 | GO:0044449 | contractile fiber part(GO:0044449) |
0.0 | 0.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.6 | GO:0044853 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
0.0 | 0.2 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.5 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 0.1 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 23.4 | GO:0005576 | extracellular region(GO:0005576) |
0.0 | 2.3 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.4 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.1 | GO:0000805 | X chromosome(GO:0000805) |
0.0 | 0.4 | GO:0019717 | obsolete synaptosome(GO:0019717) |
0.0 | 0.3 | GO:0097060 | synaptic membrane(GO:0097060) |
0.0 | 0.3 | GO:0031256 | leading edge membrane(GO:0031256) |
0.0 | 0.2 | GO:0045202 | synapse(GO:0045202) |
0.0 | 4.8 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.2 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.4 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.0 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.0 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.0 | 0.0 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.7 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.9 | GO:0045177 | apical part of cell(GO:0045177) |
0.0 | 0.4 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 0.1 | GO:0042383 | sarcolemma(GO:0042383) |
0.0 | 0.1 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.0 | 0.0 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.0 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.6 | GO:0030054 | cell junction(GO:0030054) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 2.9 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.8 | 3.4 | GO:0048495 | Roundabout binding(GO:0048495) |
0.7 | 2.2 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.7 | 4.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.6 | 5.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.6 | 1.7 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.6 | 1.7 | GO:0005113 | patched binding(GO:0005113) |
0.5 | 1.6 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.5 | 3.6 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.5 | 1.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.5 | 1.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.5 | 1.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.5 | 0.5 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.4 | 4.8 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.4 | 1.8 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.4 | 1.3 | GO:0004938 | alpha-adrenergic receptor activity(GO:0004936) alpha2-adrenergic receptor activity(GO:0004938) |
0.4 | 1.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.4 | 0.8 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.4 | 1.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.4 | 1.6 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.4 | 4.3 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.4 | 1.9 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.4 | 3.4 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.4 | 1.1 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.4 | 1.9 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.4 | 1.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.4 | 1.1 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.3 | 5.9 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.3 | 1.0 | GO:0003680 | AT DNA binding(GO:0003680) |
0.3 | 2.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 1.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.3 | 1.3 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.3 | 1.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.3 | 1.0 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.3 | 1.3 | GO:0031404 | chloride ion binding(GO:0031404) |
0.3 | 1.3 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.3 | 0.6 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.3 | 0.9 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.3 | 0.9 | GO:0050693 | LBD domain binding(GO:0050693) |
0.3 | 1.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.3 | 1.9 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.3 | 0.9 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.3 | 1.8 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.3 | 1.2 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.3 | 1.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.3 | 0.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.3 | 0.9 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.3 | 1.1 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.3 | 5.8 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.3 | 1.3 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.2 | 1.4 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 0.7 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.2 | 0.7 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.2 | 0.7 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.2 | 1.6 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.2 | 0.9 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.2 | 0.7 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 16.7 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 0.9 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.2 | 2.6 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.2 | 0.7 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.2 | 0.7 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 3.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 0.6 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.2 | 1.5 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.2 | 0.4 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.2 | 1.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 0.6 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 1.5 | GO:0030506 | ankyrin binding(GO:0030506) |
0.2 | 0.6 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 1.6 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.2 | 0.6 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.2 | 1.0 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 1.8 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.2 | 1.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.2 | 0.6 | GO:0031708 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.2 | 0.8 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.2 | 2.9 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.2 | 1.0 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.2 | 0.8 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 0.7 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 2.9 | GO:0045296 | cadherin binding(GO:0045296) |
0.2 | 0.5 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 0.5 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.2 | 3.2 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.2 | 0.7 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.2 | 0.7 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.2 | 1.0 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.2 | 2.0 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.2 | 2.1 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.2 | 0.8 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.2 | 0.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 0.5 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.2 | 1.0 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.2 | 4.6 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.2 | 0.6 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.2 | 0.5 | GO:0004103 | choline kinase activity(GO:0004103) |
0.2 | 0.6 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.2 | 2.3 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.2 | 0.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.2 | 1.4 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 0.4 | GO:0005346 | purine ribonucleotide transmembrane transporter activity(GO:0005346) |
0.1 | 0.4 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 0.3 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.1 | 0.4 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.6 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.1 | 0.4 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.1 | 2.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.4 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 1.7 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.8 | GO:0001228 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.1 | 3.6 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.8 | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.1 | 2.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.4 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.1 | 0.8 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 3.5 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.3 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 1.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 2.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.7 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 1.6 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.6 | GO:0016595 | glutamate binding(GO:0016595) |
0.1 | 0.4 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 1.4 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 0.3 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 0.4 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.8 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 0.7 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 1.7 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.7 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 1.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 0.4 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 0.8 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.1 | 0.7 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 1.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 13.4 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 0.6 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.7 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.3 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 0.3 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.1 | 1.3 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.1 | 0.8 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 0.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 0.5 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.1 | 1.3 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 0.4 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 0.5 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.3 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.3 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.8 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 0.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 1.7 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.1 | 0.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 0.8 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.3 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.1 | 0.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.3 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 0.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 0.8 | GO:0051378 | serotonin binding(GO:0051378) |
0.1 | 0.3 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.1 | 0.6 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.6 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 1.1 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.7 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 21.9 | GO:0030528 | obsolete transcription regulator activity(GO:0030528) |
0.1 | 0.9 | GO:0005272 | sodium channel activity(GO:0005272) |
0.1 | 0.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 4.0 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.4 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.4 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 1.0 | GO:0019905 | syntaxin binding(GO:0019905) |
0.1 | 0.2 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 0.3 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 0.5 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.5 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 1.4 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 0.3 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 0.8 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.1 | 0.7 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.1 | GO:1901474 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.1 | 0.2 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 0.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 1.5 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.1 | 1.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.5 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.6 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.3 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.1 | 0.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.4 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 0.2 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.1 | 0.1 | GO:0000976 | transcription regulatory region sequence-specific DNA binding(GO:0000976) |
0.1 | 0.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 4.7 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.1 | 0.9 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.1 | 0.3 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.1 | 0.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.2 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 2.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.7 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.1 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.4 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.3 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 3.0 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 0.1 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 0.6 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.2 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.1 | 0.2 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 0.2 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.1 | 0.2 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.1 | 0.3 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.1 | 0.1 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.7 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 3.5 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.1 | 0.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.1 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.1 | 2.1 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 0.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.1 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.0 | 0.1 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.2 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.5 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.0 | 4.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.1 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.0 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.4 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.6 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.3 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.2 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.1 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.0 | 0.1 | GO:0052659 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.0 | 0.7 | GO:0005267 | potassium channel activity(GO:0005267) |
0.0 | 1.3 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.2 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 0.2 | GO:0009922 | fatty acid elongase activity(GO:0009922) |
0.0 | 0.3 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.3 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 0.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 2.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.2 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.0 | 0.1 | GO:0019798 | procollagen-proline dioxygenase activity(GO:0019798) |
0.0 | 0.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.5 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.3 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.0 | 0.1 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.0 | 0.2 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.4 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.0 | 0.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.1 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 0.2 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.4 | GO:0004835 | tubulin-tyrosine ligase activity(GO:0004835) |
0.0 | 0.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.1 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.0 | 3.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.0 | GO:0016849 | phosphorus-oxygen lyase activity(GO:0016849) |
0.0 | 0.2 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 2.0 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.1 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.0 | 0.3 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.4 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.0 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) |
0.0 | 0.0 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.1 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.2 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 1.4 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.2 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.0 | 0.8 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.0 | 0.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.1 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.1 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.0 | 1.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.1 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 0.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.4 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.0 | 9.4 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.0 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.0 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 1.4 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.1 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.0 | 0.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.1 | GO:0016847 | 1-aminocyclopropane-1-carboxylate synthase activity(GO:0016847) |
0.0 | 0.0 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.0 | 0.1 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.2 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.2 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.6 | GO:0005254 | chloride channel activity(GO:0005254) |
0.0 | 0.0 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.1 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.2 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.0 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.3 | GO:0070405 | ammonium ion binding(GO:0070405) |
0.0 | 0.0 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.0 | 0.0 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.1 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.3 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.0 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.1 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.0 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.0 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.0 | 0.0 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.0 | 0.0 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 0.0 | GO:0080032 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.2 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.0 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.0 | 0.0 | GO:0005497 | androgen binding(GO:0005497) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 6.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 13.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.3 | 8.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.3 | 4.7 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.3 | 6.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.3 | 7.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.3 | 2.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 1.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.2 | 0.4 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 5.3 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 1.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 4.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 24.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 0.3 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 5.3 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.1 | 4.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 1.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 2.0 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 0.6 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 4.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 3.0 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 0.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 1.5 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 1.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 3.6 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 0.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 4.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 0.2 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 0.9 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 1.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 1.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 2.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 0.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 1.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 1.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 1.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 0.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 1.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 2.3 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 1.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 1.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 0.6 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 1.7 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 0.9 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 1.0 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 7.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 10.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 13.0 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.4 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 0.5 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.4 | 0.4 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.4 | 4.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.3 | 1.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.3 | 5.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.3 | 4.1 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.3 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.3 | 16.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.3 | 7.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 3.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.3 | 0.3 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.3 | 6.2 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.3 | 3.8 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 2.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 2.7 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 0.2 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.2 | 4.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 2.2 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.2 | 3.1 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.2 | 2.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 3.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 0.9 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.2 | 7.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 3.9 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.2 | 0.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.2 | 2.0 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.2 | 1.6 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.2 | 1.9 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 2.4 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.2 | 12.9 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 1.8 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 2.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 1.2 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 0.8 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 1.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.7 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.1 | 0.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 1.9 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.1 | 1.5 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 2.1 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 1.2 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.1 | 1.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 0.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 1.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 0.2 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.1 | 0.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 0.9 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.1 | 0.5 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 0.6 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 1.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.6 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 0.8 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 1.0 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 0.7 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 0.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 1.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 1.9 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 2.2 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.1 | 0.8 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 0.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.1 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 1.8 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 0.7 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 0.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 0.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 1.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 0.9 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 2.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 0.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.4 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 1.6 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 1.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 0.9 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 0.7 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 0.9 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.0 | 0.2 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.5 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 1.8 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.1 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.0 | 0.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.9 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.3 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.5 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.1 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 1.2 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.0 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 1.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.0 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 0.2 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.0 | 0.4 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 1.3 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.1 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.1 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.0 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.0 | 0.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |